Stigmatization of alcohol and other drug users by primary care providers in Southeast Brazil

Ronzani, Telmo Mota; Higgins-Biddle, John C; Furtado, Erikson Felipe

doi:10.1016/j.socscimed.2009.07.026

Cited by 141 publications

(113 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On the other hand, negative attitudes from mental health professionals were identified in most, 21 but not all of the reports. 20 In a study with a sample of 1,414 psychiatrists, Loch et al 8 reported that the respondents endorsed negative attitudes and social distance toward people with schizophrenia.…”

Section: Public Stigmamentioning

confidence: 99%

Stigma toward mental illness in Latin America and the Caribbean: a systematic review

Mascayano

Tapia

Schilling

et al. 2016

Rev. Bras. Psiquiatr.

125

111

View full text Add to dashboard Cite

Artículo de publicación ISIObjective: Stigma toward individuals with mental disorders has been studied extensively. In the case of Latin America and the Caribbean, the past decade has been marked by a significant increase in information on stigma toward mental illness, but these findings have yet to be applied to mental health services in Latin America. The objective of this study was to conduct a systematic review of studies relating to stigma toward mental illness in Latin America and the Caribbean. The authors specifically considered differences in this region as compared with manifestations reported in Western European countries. Methods: A systematic search of scientific papers was conducted in the PubMed, MEDLINE, EBSCO, SciELO, LILACS, Imbiomed, and Bireme databases. The search included articles published from 2002 to 2014. Results: Twenty-six studies from seven countries in Latin America and the Caribbean were evaluated and arranged into the following categories: public stigma, consumer stigma, family stigma, and multiple stigmas. Conclusion: We identified some results similar to those reported in high-income settings. However, some noteworthy findings concerning public and family stigma differed from those reported in Western European countries. Interventions designed to reduce mental illness-related stigma in this region may benefit from considering cultural dynamics exhibited by the Latino population.National Institute of Mental Health U19MH09571

show abstract

Section: Public Stigmamentioning

confidence: 99%

Stigma toward mental illness in Latin America and the Caribbean: a systematic review

Mascayano

Tapia

Schilling

et al. 2016

Rev. Bras. Psiquiatr.

125

111

View full text Add to dashboard Cite

show abstract

“…22,23 Patients with hepatitis C infection may be stigmatized by health care providers due to hepatitis C's association with injection drug use. 24 One study found that the drug user stigma was associated with risky injection behaviors among injection drug users in India.…”

Section: Introductionmentioning

confidence: 99%

The Relationship between Drug User Stigma and Depression among Inner-City Drug Users in Baltimore, MD

et al. 2012

View full text Add to dashboard Cite

There is growing awareness of the role of stigma and discrimination in HIV prevention, testing, and medical care. Yet, few studies have examined the stigma associated with using illicit drugs. In the present study, we examined the relationship between social network characteristics, drug user stigma, and depression. Study participants were comprised of 340 individuals who reported cocaine, crack, and/or heroin use in the prior 6 months and were involved in an HIV prevention study. They were recruited through street outreach, referrals, and word of mouth in inner-city Baltimore, MD, USA. The stigma scale was comprised of eight items, such as "how much do you feel ashamed of using drugs?" Depression was assessed with the Center for Epidemiological Studies Depression Scale, using cutoffs of 16 and 20 or greater. In the bivariate analyses, gender, homelessness in the past 6 months, drug user stigma, larger size of drug network, and current use of heroin, cocaine, and crack were all significantly associated with high levels of depression, whereas in the multivariate analyses, only drug user stigma remained significantly associated with depression. The results of this study suggest that drug treatment providers and other professionals who provide services to drug users should consider developing trainings to address drug user stigma. These programs should focus on the attitudes and behaviors of health and service providers toward drug users, among drug users themselves, and among family members and others who provide social support to drug users.

show abstract

“…[21][22][23][24][25] Alcoholism is stigmatized, even among health care providers, 26,27 who may expect patients to object when the topic is raised 1,28,29 and to under-report consumption and problems. 26,30 Anecdotally, we did occasionally field questions from patients about whether their provider thought they were Ban alcoholic.^Thus, a common misconception may be that a doctor would only be concerned about a patient's drinking if there was a suspected AUD.…”

Section: Discussionmentioning

confidence: 99%

A Randomized Controlled Trial of IVR-Based Alcohol Brief Intervention to Promote Patient–Provider Communication in Primary Care

et al. 2016

View full text Add to dashboard Cite

BACKGROUND: Brief interventions for unhealthy drinking in primary care settings are efficacious, but underutilized. Efforts to improve rates of brief intervention though provider education and office systems redesign have had limited impact. Our novel brief intervention uses interactive voice response (IVR) to provide information and advice directly to unhealthy drinkers before a physician office visit, with the goals of stimulating in-office dialogue about drinking and decreasing unhealthy drinking. This automated approach is potentially scalable for wide application. OBJECTIVE: We aimed to examine the effect of a pre-visit IVR-delivered brief alcohol intervention (IVR-BI) on patient-provider discussions of alcohol during the visit. DESIGN: This was a parallel group randomized controlled trial with two treatment arms: 1) IVR-BI or 2) usual care (no IVR-BI). PARTICIPANTS: In all, 1,567 patients were recruited from eight university medical center-affiliated internal medicine and family medicine clinics. INTERVENTIONS: IVR-BI is a brief alcohol intervention delivered by automated telephone. It has four components, based on the intervention steps outlined in the National Institute of Alcohol Abuse and Alcoholism guidelines for clinicians: 1) ask about alcohol use, 2) assess for alcohol use disorders, 3) advise patient to cut down or quit drinking, and 4) follow up at subsequent visits. MAIN MEASURES: Outcomes were patient reported: patient-provider discussion of alcohol during the visit; patient initiation of the discussion; and provider's recommendation about the patient's alcohol use. KEY RESULTS: Patients randomized to IVR-BI were more likely to have reported discussing alcohol with their provider (52 % vs. 44 %, p = 0.003), bringing up the topic themselves (20 % vs. 12 %, p < 0.001), and receiving a recommendation (20 % vs. 14 %, p < 0.001). Other predictors of outcome included baseline consumption, education, age, and alcohol use disorder diagnosis. CONCLUSIONS: Providing automated brief interventions to patients prior to a primary care visit promotes discussion about unhealthy drinking and increases specific professional advice regarding changing drinking behavior.

show abstract

Stigmatization of alcohol and other drug users by primary care providers in Southeast Brazil

Cited by 141 publications

References 15 publications

Stigma toward mental illness in Latin America and the Caribbean: a systematic review

Stigma toward mental illness in Latin America and the Caribbean: a systematic review

The Relationship between Drug User Stigma and Depression among Inner-City Drug Users in Baltimore, MD

A Randomized Controlled Trial of IVR-Based Alcohol Brief Intervention to Promote Patient–Provider Communication in Primary Care

Contact Info

Product

Resources

About